Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

H Reinhard, Peter Karl Jacobsen, Marianne Lajer, N Pedersen, Nils Billestrup, Thomas Mandrup-Poulsen, H-H Parving, Pia Rossing

    35 Citationer (Scopus)

    Abstract

    Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.
    OriginalsprogEngelsk
    TidsskriftDiabetologia
    Vol/bind53
    Udgave nummer10
    Sider (fra-til)2129-33
    Antal sider5
    ISSN0012-186X
    DOI
    StatusUdgivet - 1 okt. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes'. Sammen danner de et unikt fingeraftryk.

    Citationsformater